The Dust Settles: Healthcare M&A Activity Simmers Down
After a strong start to the year, deal activity has finally cooled off. During February, there were 135 healthcare deals, a 53% decrease from January 2022, which had a record-breaking 290 deals. Such a drastic drop is to be expected. The market naturally goes into an ebb and flow, and historically, January is always much busier than February. Additionally, the deal total last month wasn’t far off from what we saw in February 2021, when there were 142 deals across all sectors. The busiest sector during February 2022 was Other Services, which had 32 announced transactions across a wide range of sectors, including medical office buildings, ambulatory surgery centers, contract research... Read More »
Another Avalanche: January Deal Volume Breaks Record
The new year is already off to a strong start. Deal activity in January hit a record high with 352 deals across all sectors, beating out the previous record of 293 deals in January 2021. An impressive feat, considering the many headwinds currently facing the market. We expect this number to continue to rise as more January deals continue to be announced. 2021 was a record-breaking year for deal activity, with 2,599 deals on the books so far. However, if January’s strong showing foreshadows the rest of the year, 2022 may shatter the prior year’s record. The busiest sector during January 2021 was Physician Medical Groups (PMG), with 77 announced deals, making up 22% of all deals across... Read More »
November Healthcare M&A Deal Volume Soars
The penultimate month of 2021 did not disappoint. There were 229 deals announced in November. It’s a mere five deals more than what dealmakers announced or closed in October, but the fourth quarter is shaping up to be a historic era of activity. Most of the deal activity remains focused on the lower market, highlighting the fragmentation of the market, meaning there are plenty of targets left for equity buyers and strategic investors. Aside just from a natural cooling off of the market, the only major headwind on the way is the Omicron variant, which has already hit the United States. Its been rattling public markets; Moderna and Pfizer are quickly pivoting to develop... Read More »
The Transcript: Q3 Highlights From Healthcare CEOs
What better way to get an understanding of the healthcare market than through the CEOs of the top companies themselves? Leaders across different segments, including hospitals, telehealth, managed care, home health and more, reported strong growth and activity and have a confident outlook for the final quarter of 2021. Membership Drive “We ended the quarter with 715,000 members, 18,000 above the high end of our updated guidance from September 1, up 40% year-over-year. Similarly, our revenue also has outperformed coming in at $151 million, $3 million above the high end of our updated guidance from September, up 49% year-over-year.” – Amir Rubin, President and CEO of One Medical“We were... Read More »